Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 181

Sort by

Sort Order Select

Journal Articles

Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystroph y

Yael Lebenthal, Sharon Halperin, Hagar Interator, Avivit Brener, Rebecca J. Brown

Diabetes Care 2025;48(5):e71–e73

https://doi.org/10.2337/dc25-0272

Published: 19 March 2025

View articletitled, Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystroph y

Journal Articles

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, Jeevitha Prativadi, Eric D. Frontera, Maria Cristina Foss-Freitas, Noura Nachawi, David T. Broome, Marissa Lightbourne, Rebecca J. Brown, Simeon I. Taylor, Elif A. Oral

Diabetes Care 2025;48(5):756–762

https://doi.org/10.2337/dc24-2408

Published: 10 March 2025

View articletitled, Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Journal Articles

Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

Yimeng Zhou, Yongzhen Zhai

Diabetes Care 2025;48(3):e31

https://doi.org/10.2337/dc24-1777

Published: 20 February 2025

View articletitled, Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

Journal Articles

Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

Maria C. Foss-Freitas, David T. Broome, Elif A. Oral

Diabetes Care 2025;48(3):e32

https://doi.org/10.2337/dci24-0080

Published: 20 February 2025

View articletitled, Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

Journal Articles

The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research

David A. D’Alessio, Steven E. Kahn

Diabetes Care 2025;48(1):3–5

https://doi.org/10.2337/dci24-0092

Published: 20 December 2024

View articletitled, The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research

Journal Articles

Summary of Revisions: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, Mandeep Bajaj, Kirthikaa Balapattabi, Elizabeth A. Beverly, Kathaleen Briggs Early, Dennis Bruemmer, Brian C. Callaghan, Kenneth Cusi, Sandeep R. Das, Osagie Ebekozien, Justin B. Echouffo-Tcheugui, Barbara Eichorst, Laya Ekhlaspour, Talya K. Fleming, Robert G. Frykberg, Jason L. Gaglia, Rodolfo J. Galindo, Rajesh Garg, Sunir J. Garg, Monica Girotra, John M. Giurini, Mohamed Hassanein, Kamlesh Khunti, Mikhail N. Kosiborod, Robert F. Kushner, Rayhan Lal, Seymour R. Levin, Ildiko Lingvay, Glenn Matfin, Roeland J.W. Middelbeek, Lisa Murdock, Nicola Napoli, Joshua J. Neumiller, Naushira Pandya, Sharon J. Parish, Elizabeth J. Pekas, Scott J. Pilla, Flavia Q. Pirih, Sarit Polsky, Alissa R. Segal, Jane Jeffrie Seley, Elizabeth Selvin, Shylaja Srinivasan, Robert C. Stanton, Molly L. Tanenbaum, Patti Urbanski, Monica Verduzco-Gutierrez, Crystal C. Woodward, Zobair M. Younossi, Raveendhara R. Bannuru

Diabetes Care 2025;48(Supplement_1):S6–S13

https://doi.org/10.2337/dc25-SREV

Published: 09 December 2024

View articletitled, Summary of Revisions: Standards of Care in Diabetes—2025

Journal Articles

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

Diabetes Care 2025;48(Supplement_1):S181–S206

https://doi.org/10.2337/dc25-S009

Published: 09 December 2024

View articletitled, 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

Journal Articles

Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity

Daniel J. Drucker

Diabetes Care 2024;47(11):1873–1888

https://doi.org/10.2337/dci24-0003

Published: 06 June 2024

View articletitled, Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity

Journal Articles

Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S158–S178

Diabetes Care 2024;47(7):1238

https://doi.org/10.2337/dc24-er07a

Published: 02 May 2024

View articletitled, Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S158–S178

Journal Articles

β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Giuseppe Daniele, Andrea Tura, Alex Brocchi, Alessandro Saba, Beatrice Campi, Veronica Sancho-Bornez, Angela Dardano, Stefano Del Prato

Diabetes Care 2024;47(7):1131–1139

https://doi.org/10.2337/dc23-2051

Published: 23 April 2024

View articletitled, β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Journal Articles

Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

Mary S. Anthony, Vanita R. Aroda, Lauren E. Parlett, Leila Djebarri, Sofia Berreghis, Brian Calingaert, Daniel C. Beachler, Christopher L. Crowe, Catherine B. Johannes, Juhaeri Juhaeri, Stephan Lanes, Chunshen Pan, Kenneth J. Rothman, Catherine W. Saltus, Kathleen E. Walsh

Diabetes Care 2024;47(4):712–719

https://doi.org/10.2337/dc23-1911

Published: 16 February 2024

View articletitled, Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

Journal Articles

Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy

Maria C. Foss-Freitas, Salman Imam, Adam Neidert, Anabela Dill Gomes, David T. Broome, Elif A. Oral

Diabetes Care 2024;47(4):653–659

https://doi.org/10.2337/dc23-1614

Published: 01 February 2024

View articletitled, Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy

Journal Articles

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024

Diabetes Care 2024;47(Supplement_1):S158–S178

https://doi.org/10.2337/dc24-S009

Published: 11 December 2023

View articletitled, 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024

Journal Articles

Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Diabetes Care 2024;47(1):160–168

https://doi.org/10.2337/dc23-1287

Published: 09 November 2023

View articletitled, Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Journal Articles

Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression

Sandra C. Naaman, George L. Bakris

Diabetes Care 2023;46(9):1574–1586

https://doi.org/10.2337/dci23-0030

Published: 25 August 2023

View articletitled, Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression

Journal Articles

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Ronald M. Goldenberg, Akshay B. Jain

Diabetes Care 2023;46(5):e117

https://doi.org/10.2337/dc22-2300

Published: 26 April 2023

View articletitled, Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Journal Articles

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Mark M. Smits, Daniël H. van Raalte

Diabetes Care 2023;46(5):e120

https://doi.org/10.2337/dc23-0134

Published: 26 April 2023

View articletitled, Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Journal Articles

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Ana B. Mañas-Martinez, Jose A. Gimeno-Orna

Diabetes Care 2023;46(5):e119

https://doi.org/10.2337/dc23-0076

Published: 26 April 2023

View articletitled, Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Journal Articles

Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts

Caroline A. Thompson, Til Stürmer

Diabetes Care 2023;46(2):249–251

https://doi.org/10.2337/dci22-0052

Published: 16 December 2022

View articletitled, Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts

Journal Articles

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Sara J. Cromer, Julie C. Lauffenburger, Raisa Levin, Elisabetta Patorno

Diabetes Care 2023;46(1):65–74

https://doi.org/10.2337/dc22-0383

Published: 16 November 2022

View articletitled, Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Update search

NARROW

Format

Journal

Article Type

Topics

Subjects

Issue Section

Date

Availability

Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystroph y

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research

Summary of Revisions: Standards of Care in Diabetes—2025

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity

Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S158–S178

β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024

Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only